APTO Aptose Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: APTO

Price (delayed)

$0.58

Market cap

$9.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.2

Enterprise value

$3.03M

Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics ...

Highlights
The debt has contracted by 25% YoY and by 9% from the previous quarter
The EPS has grown by 18% since the previous quarter and by 13% year-on-year
Aptose Biosciences's equity has surged by 105% QoQ but it has shrunk by 99% YoY
The quick ratio has plunged by 73% YoY but it has increased by 26% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://aptose.com
Peers: CRBP AGEN INCY

Key stats

What are the main financial stats of APTO
Market
Shares outstanding
16.31M
Market cap
$9.46M
Enterprise value
$3.03M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
66.54
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$47.17M
EBITDA
-$46.73M
Free cash flow
-$45.09M
Per share
EPS
-$6.2
Free cash flow per share
-$3.43
Book value per share
$0.01
Revenue per share
$0
TBVPS
$0.97
Balance sheet
Total assets
$12.8M
Total liabilities
$12.66M
Debt
$919,000
Equity
$137,000
Working capital
-$318,000
Liquidity
Debt to equity
6.71
Current ratio
0.97
Quick ratio
0.77
Net debt/EBITDA
0.14
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-257.6%
Return on equity
-1,003.7%
Return on invested capital
N/A
Return on capital employed
-7,179.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

APTO stock price

How has the Aptose Biosciences stock price performed over time
Intraday
-4.92%
1 week
-10.77%
1 month
-20.55%
1 year
-85.82%
YTD
-77.17%
QTD
-23.68%

Financial performance

How have Aptose Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$48.02M
Net income
-$47.17M
Gross margin
N/A
Net margin
N/A
Aptose Biosciences's net income has increased by 8% from the previous quarter but it has decreased by 7% YoY
The company's operating income rose by 8% QoQ but it fell by 6% YoY

Growth

What is Aptose Biosciences's growth rate over time

Valuation

What is Aptose Biosciences stock price valuation
P/E
N/A
P/B
66.54
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 18% since the previous quarter and by 13% year-on-year
Aptose Biosciences's equity has surged by 105% QoQ but it has shrunk by 99% YoY

Efficiency

How efficient is Aptose Biosciences business performance
APTO's return on equity has dropped by 119% since the previous quarter
The return on assets has declined by 25% since the previous quarter

Dividends

What is APTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APTO.

Financial health

How did Aptose Biosciences financials performed over time
The quick ratio has plunged by 73% YoY but it has increased by 26% from the previous quarter
The company's current ratio has shrunk by 68% YoY but it rose by 24% QoQ
Aptose Biosciences's equity has surged by 105% QoQ but it has shrunk by 99% YoY
The debt has contracted by 25% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.